Crystallization Strategies the Quest for Increased Yield and Chiral Purity
Optimal Form Screening and Selection by Controlled Crystallization
Solvent Selection in Pharmaceutical Crystallisation Process Development
Revealing Shapes: Particle Morphology Hints Impurity Rejection Capability during API Crystallization
Linking Solution Chemistry to Crystallization
Viedma Ripening and Temperature Cycling: Two Robust Deracemization Methods
Accurate Measurement and Validation of Solubility Data for Polymorphic Compounds
Growing X-ray Quality Single Crystals
Crystallization Monitoring with Raman Spectroscopy
The Use of Simulation Tools for Crystallisation Process Development
Post Rationalisation of Disorder, Metastable Polymorphs and Extreme Crystallisation Conditions
Measuring Solubility & Crystallization Behaviour
Chiral Resolution and Deracemization Through Co-crystallization
Chirality in Pharmaceutical Compounds and Absolute Configuration Determination
Crystallization Screenings: a Practical Overview
Secondary Nucleation through a single crystal seeding approach
Particle Size Control during Recrystallization and Scale-up
Modeling Approaches to Increase the Efficiency of Clear-Point-Based Solubility
